Author:
Portier Bryce P,Wang Zhen,Downs-Kelly Erinn,Rowe Jordi J,Patil Deepa,Lanigan Chis,Budd G Thomas,Hicks David G,Rimm David L,Tubbs Raymond R
Publisher
Springer Science and Business Media LLC
Subject
Pathology and Forensic Medicine
Reference27 articles.
1. Baselga J, Norton L, Albanell J et al Recombinant humanized anti-HER2 antibody (Herceptin) enhances the antitumor activity of paclitaxel and doxorubicin against HER2/neu overexpressing human breast cancer xenografts. Cancer Res 1998;58:2825–2831.
2. Paik S, Kim C, Wolmark N . HER2 status and benefit from adjuvant trastuzumab in breast cancer. N Engl J Med 2008;358:1409–1411.
3. Slamon DJ, Leyland-Jones B, Shak S et al Use of chemotherapy plus a monoclonal antibody against HER2 for metastatic breast cancer that overexpresses HER2. N Engl J Med 2001;344:783–792.
4. Pietras RJ, Pegram MD, Finn RS et al Remission of human breast cancer xenografts on therapy with humanized monoclonal antibody to HER-2 receptor and DNA-reactive drugs. Oncogene 1998;17:2235–2249.
5. Pegram M, Hsu S, Lewis G et al Inhibitory effects of combinations of HER-2/neu antibody and chemotherapeutic agents used for treatment of human breast cancers. Oncogene 1999;18:2241–2251.
Cited by
77 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献